SRF has commissioned and capitalised on a pharmaceutical intermediates plant at Dahej in Gujarat, on 12 April 2023. The project entailed a cost of approx. Rs 223 crore.
The plant will undertake precursor processes for the production of pharmaceutical products. In May 2022, the company’s Board granted approval to a project for dedicated facilities to produce intermediates for agrochemicals at Dahej.
SRF is engaged in the manufacturing of industrial and specialty intermediates and has a diversified business portfolio across fluorochemicals, specialty chemicals, technical textiles, and coated and laminated fabrics.